Compare · APGB vs MLEC
APGB vs MLEC
Side-by-side comparison of Apollo Strategic Growth Capital II (APGB) and Moolec Science SA (MLEC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APGB and MLEC operate in Blank Checks (Finance), so they compete in similar markets.
- APGB is the larger of the two at $836.6M, about 161.4x MLEC ($5.2M).
- MLEC has hit the wire 1 time in the past 4 weeks while APGB has been quiet.
- MLEC has more recent analyst coverage (1 ratings vs 0 for APGB).
APGB
Apollo Strategic Growth Capital II
Apollo Strategic Growth Capital II intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as APH I (Sub I), Ltd. and changed its name to Apollo Strategic Growth Capital II in December 2020. Apollo Strategic Growth Capital II was incorporated in 2008 and is based in New York, New York.
Latest APGB
- SEC Form SC 13G/A filed by Apollo Strategic Growth Capital II (Amendment)
- SEC Form SC 13G/A filed by Apollo Strategic Growth Capital II (Amendment)
- SEC Form SC 13G filed by Apollo Strategic Growth Capital II
- SEC Form 15-12G filed by Apollo Strategic Growth Capital II
- SEC Form 25-NSE filed by Apollo Strategic Growth Capital II
- SEC Form 10-Q filed by Apollo Strategic Growth Capital II
- Apollo Strategic Growth Capital II filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Apollo Strategic Growth Capital II Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination; Per-Share Redemption Price For The Public Shares Will Be ~$10.58
- Apollo Strategic Growth Capital II Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination
- SEC Form 10-Q filed by Apollo Strategic Growth Capital II
Latest MLEC
- SEC Form 6-K filed by Moolec Science SA
- SEC Form 6-K filed by Moolec Science SA
- Moolec Science Successfully Completes 2026 GLASO Commercial Planting Campaign in the United States
- SEC Form 6-K filed by Moolec Science SA
- Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period
- SEC Form 6-K filed by Moolec Science SA
- Moolec Science Confirms Completion of First Phase of GLASO Industrialization Following Record 2025 Campaign; Advances 2026 Sowing and Expands Into Energy Applications
- SEC Form 6-K filed by Moolec Science SA
- SEC Form 3 filed by new insider Core Daniel Joaquin
- Moolec Science Announces Breakthrough in Molecular Farming With Successful Expression of Bovine Myoglobin in Pea Seeds